Orinox Ha (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride, the active ingredient in Orinox Ha, is an alpha‑adrenergic nasal decongestant presented as a nasal spray for topical intranasal use. It relieves nasal congestion associated with common colds, sinusitis and allergic rhinitis in adults and children. GNH USA supplies Orinox Ha as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Orinox Ha as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Orinox Ha contains Xylometazoline, a topical decongestant that acts on the nasal mucosa to reduce swelling and improve airflow.

- Common cold: Reduces nasal blockage and improves breathing. - Acute sinusitis: Alleviates congestion and facilitates sinus drainage. - Allergic rhinitis: Decreases nasal swelling and mucus production. - Nasal surgery recovery: Helps keep nasal passages clear post‑operatively. - Travel‑related congestion: Relieves pressure changes during air travel.

Xylometazoline nasal spray is generally well‑tolerated, but adverse reactions can occur.

Common Side Effects: -  t  t   ---   t  R ​   t  t ---  \n Serious or Rare  t  --- \\  \

t \    ewline   ewline

t \   ewline  ewline  ewline  ewline

Orion​    t ​  ewline \n   ewline \